Nasdaq Grants iTonic Holdings Ltd an Additional 180-Day Extension to Regain Compliance with the Minimum Bid Price Rule

(SeaPRwire) –   BEIJING, China, April 23, 2026 — iTonic Holdings Ltd (the “Company” or “ITOC”), a provider of healthcare solutions focused on treatment planning systems for brachytherapy and associated services, announced on April 21, 2026, that The Nasdaq Stock Market LLC (“Nasdaq”) has granted its request for an additional 180-calendar day period. This extension, valid until October 19, 2026 (the “Extension”), is intended to allow the Company to regain compliance with the minimum closing bid price requirement defined in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). This Extension was granted following the conclusion of the initial 180-calendar day compliance period on April 20, 2026.

Nasdaq has informed the Company that if it fails to meet the Minimum Bid Price Rule by October 19, 2026, a written notification will be sent indicating that the Company’s Class A ordinary shares are subject to delisting. Should this occur, the Company reserves the right to appeal the delisting decision by requesting a hearing before a Nasdaq Hearings Panel.

About iTonic Holdings Ltd

Established in 1998, iTonic Holdings Ltd operates through its wholly-owned subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., to deliver healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer care. The Company’s primary offering, the Beijing Feitian Treatment Planning System, is designed to ensure the safety and efficacy of brachytherapy procedures that use internal radioactive sources to eliminate cancer cells and reduce tumors. iTonic Holdings Ltd is dedicated to using its products and services to create a potential new standard of care for various malignant tumor types. Additional information is available at: http://www.ftzy.com.cn/ir.

Safe Harbor Statement

This announcement includes forward-looking statements governed by the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements, which relate to ITOC’s cash position, financial capabilities, growth prospects, market acceptance of new or planned products, and future financial performance, are not historical facts and involve inherent risks and uncertainties. They can be identified by the use of terms such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “hope,” “going forward,” “intend,” “ought to,” “plan,” “project,” “potential,” “seek,” “may,” “might,” “can,” “could,” “will,” “would,” “shall,” “should,” “is likely to,” and their negatives. Actual results may differ materially from those projected due to various factors. The information in this press release is based on assumptions deemed reasonable as of the date hereof, and the Company undertakes no obligation to update any forward-looking statements except as required by law.

For investor and media inquiries, please contact:

iTonic Holdings Ltd
Investor Relations
Email: ir@ftzy.com.cn 

Lambert by LLYC
Jackson Lin
Phone: +1-646-717-4593
Email: jian.lin@llyc.global